A HealthTech Report: Oxytocin in Uniject: Market Landscape Analysis

This study was an external analysis of the viability of supporting oxytocin in the Uniject™ injection system as a niche product in both the public and private sectors globally. A major component of this analysis was to conduct separate market analyses of 30 countries identified by the US Agency for International Development as priority countries for maternal health interventions.

Publication date: June 2011

A HealthTech Report: Oxytocin in Uniject: Market Landscape Analysis

861.7 KB PDF
Hard copies are not available.
View Resource